In this regard, larger studies including longitudinal samples of HD symptomatic and pre-symptomatic subjects are needed to fully elucidate the dynamics of CSF PENK and PDYN levels during disease course and to evaluate their potential predictive role in the pre-symptomatic phase. This evidence concerns the gene PENK and Huntington disease.